Abstract
Congenital disorder of glycosylation (CDG), formerly representing a group of diseases due to defects in the biosynthetic pathway of protein N-glycosylation, currently covers a wide range of disorders affecting glycoconjugates. Since its first application to serum transferrin from a CDG patient with phosphomannomutase-2 deficiency in 1992, mass spectrometry (MS) has been playing a key role in identification and characterization of glycosylation defects affecting glycoproteins. MS of native transferrin detects a lack of glycans characteristic to the classical CDG-I type of molecular abnormality. Electrospray ionization MS of native transferrin, especially, allows glycoforms to be analyzed precisely but requires basic knowledge regarding deconvolution of multiply-charged ions which may generate ghost signals upon transformation into a singly-charged form. MS of glycopeptides from tryptic digestion of transferrin delineates site-specific glycoforms and reveals a delicate balance of donor/acceptor substrates or the conformational effect of nascent proteins in cells. Matrix-assisted laser desorption ionization MS of apolipoprotein C-III is a simple method of elucidating the profiles of mucin-type core 1 O-glycans including site occupancy and glycoforms. In this technological review, the principle and pitfalls of MS for CDG are discussed and mass spectra of various types of CDG are presented.
Similar content being viewed by others
References
Wada Y., Nishikawa A., Okamoto N., Inui K., Tsukamoto H., Okada S., Taniguchi N.: Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem. Biophys. Res. Commun. 189(2), 832–836 (1992)
Jaeken J., van Eijk H.G., van der Heul C., Corbeel L., Eeckels R., Eggermont E.: Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin. Chim. Acta. 144(2–3), 245–247 (1984)
Stibler H., Jaeken J.: Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch. Dis. Child. 65(1), 107–111 (1990)
Babovic-Vuksanovic D., O'Brien J.F.: Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms. Mol. Diagn. Ther. 11(5), 303–311 (2007)
Barone R., Sturiale L., Garozzo D.: Mass spectrometry in the characterization of human genetic N-glycosylation defects. Mass Spectrom. Rev. 28(3), 517–542 (2009). doi:10.1002/mas.20201
Faid V., Chirat F., Seta N., Foulquier F., Morelle W.: A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis. Proteomics. 7(11), 1800–1813 (2007). doi:10.1002/pmic.200600977
Hennet T.: Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim. Biophys. Acta. 1820(9), 1306–1317 (2012). doi:10.1016/j.bbagen.2012.02.001
Jaeken J., Carchon H.: The carbohydrate-deficient glycoprotein syndromes: an overview. J. Inherit. Metab. Dis. 16(5), 813–820 (1993)
Scott K., Gadomski T., Kozicz T., Morava E.: Congenital disorders of glycosylation: new defects and still counting. J. Inherit. Metab. Dis. 37(4), 609–617 (2014). doi:10.1007/s10545-014-9720-9
Barone R., Fiumara A., Jaeken J.: Congenital disorders of glycosylation with emphasis on cerebellar involvement. Semin. Neurol. 34(3), 357–366 (2014). doi:10.1055/s-0034-1387197
Freeze H.H.: Congenital disorders of glycosylation: CDG-I, CDG-II, and beyond. Curr. Mol. Med. 7(4), 389–396 (2007)
Marquardt T., Denecke J.: Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur. J. Pediatr. 162(6), 359–379 (2003). doi:10.1007/s00431-002-1136-0
Schachter H., Jaeken J.: Carbohydrate-deficient glycoprotein syndrome type II. Biochim. Biophys. Acta. 1455(2–3), 179–192 (1999)
Reynders E., Foulquier F., Annaert W., Matthijs G.: How golgi glycosylation meets and needs trafficking: the case of the COG complex. Glycobiology. 21(7), 853–863 (2011). doi:10.1093/glycob/cwq179
Lacey J.M., Bergen H.R., Magera M.J., Naylor S., O'Brien J.F.: Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin. Chem. 47(3), 513–518 (2001)
Zuhlsdorf A., Park J.H., Wada Y., Rust S., Reunert J., DuChesne I., Gruneberg M., Marquardt T.: Transferrin variants: pitfalls in the diagnostics of congenital disorders of glycosylation. Clin. Biochem. 48(1–2), 11–13 (2015). doi:10.1016/j.clinbiochem.2014.09.022
Sturiale L., Barone R., Palmigiano A., Ndosimao C.N., Briones P., Adamowicz M., Jaeken J., Garozzo D.: Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS. Proteomics. 8(18), 3822–3832 (2008). doi:10.1002/pmic.200700496
Wada Y., Gu J., Okamoto N., Inui K.: Diagnosis of carbohydrate-deficient glycoprotein syndrome by matrix-assisted laser desorption time-of-flight mass spectrometry. Biol. Mass. Spectrom. 23(2), 108–109 (1994). doi:10.1002/bms.1200230211
Burda P., Borsig L., de Rijk-van Andel J., Wevers R., Jaeken J., Carchon H., Berger E.G., Aebi M.: A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J. Clin. Invest. 102(4), 647–652 (1998). doi:10.1172/JCI2266
Rymen D., Peanne R., Millon M.B., Race V., Sturiale L., Garozzo D., Mills P., Clayton P., Asteggiano C.G., Quelhas D., Cansu A., Martins E., Nassogne M.C., Goncalves-Rocha M., Topaloglu H., Jaeken J., Foulquier F., Matthijs G.: MAN1B1 deficiency: an unexpected CDG-II. PLoS Genet. 9(12), e1003989 (2013). doi:10.1371/journal.pgen.1003989
Martinez-Duncker I., Dupre T., Piller V., Piller F., Candelier J.J., Trichet C., Tchernia G., Oriol R., Mollicone R.: Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the golgi CMP-sialic acid transporter. Blood. 105(7), 2671–2676 (2005). doi:10.1182/blood-2004-09-3509
Charuk J.H., Tan J., Bernardini M., Haddad S., Reithmeier R.A., Jaeken J., Schachter H.: Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS). Eur. J. Biochem. 230(2), 797–805 (1995)
De Praeter C.M., Gerwig G.J., Bause E., Nuytinck L.K., Vliegenthart J.F., Breuer W., Kamerling J.P., Espeel M.F., Martin J.J., De Paepe A.M., Chan N.W., Dacremont G.A., Van Coster R.N.: A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am. J. Hum. Genet. 66(6), 1744–1756 (2000)
Peters V., Penzien J.M., Reiter G., Korner C., Hackler R., Assmann B., Fang J., Schaefer J.R., Hoffmann G.F., Heidemann P.H.: Congenital disorder of glycosylation IId (CDG-IId) – a new entity: clinical presentation with dandy-walker malformation and myopathy. Neuropediatrics. 33(1), 27–32 (2002). doi:10.1055/s-2002-23597
Ng B.G., Buckingham K.J., Raymond K., Kircher M., Turner E.H., He M., Smith J.D., Eroshkin A., Szybowska M., Losfeld M.E., Chong J.X., Kozenko M., Li C., Patterson M.C., Gilbert R.D., Nickerson D.A., Shendure J., Bamshad M.J.: University of Washington center for mendelian, G., freeze, H.H.: mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am. J. Hum. Genet. 92(4), 632–636 (2013). doi:10.1016/j.ajhg.2013.03.012
Tajiri M., Yoshida S., Wada Y.: Differential analysis of site-specific glycans on plasma and cellular fibronectins: application of a hydrophilic affinity method for glycopeptide enrichment. Glycobiology. 15(12), 1332–1340 (2005). doi:10.1093/glycob/cwj019
Wada Y., Azadi P., Costello C.E., Dell A., Dwek R.A., Geyer H., Geyer R., Kakehi K., Karlsson N.G., Kato K., Kawasaki N., Khoo K.H., Kim S., Kondo A., Lattova E., Mechref Y., Miyoshi E., Nakamura K., Narimatsu H., Novotny M.V., Packer N.H., Perreault H., Peter-Katalinic J., Pohlentz G., Reinhold V.N., Rudd P.M., Suzuki A., Taniguchi N.: Comparison of the methods for profiling glycoprotein glycans–HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology. 17(4), 411–422 (2007). doi:10.1093/glycob/cwl086
Wada Y., Tajiri M., Yoshida S.: Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal. Chem. 76(22), 6560–6565 (2004). doi:10.1021/ac049062o
Gill D.J., Chia J., Senewiratne J., Bard F.: Regulation of O-glycosylation through golgi-to-ER relocation of initiation enzymes. J. Cell Biol. 189(5), 843–858 (2010). doi:10.1083/jcb.201003055
Wopereis S., Grunewald S., Morava E., Penzien J.M., Briones P., Garcia-Silva M.T., Demacker P.N., Huijben K.M., Wevers R.A.: Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin. Chem. 49(11), 1839–1845 (2003)
Wada Y., Kadoya M., Okamoto N.: Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient. Glycobiology. 22(8), 1140–1144 (2012). doi:10.1093/glycob/cws086
Yen-Nicolay S., Boursier C., Rio M., Lefeber D.J., Pilon A., Seta N., Bruneel A.: MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis. Proteomics Clin. Appl. 9(7–8), 787–793 (2015). doi:10.1002/prca.201400187
Morava E., Wopereis S., Coucke P., Gillessen-Kaesbach G., Voit T., Smeitink J., Wevers R., Grunewald S.: Defective protein glycosylation in patients with cutis laxa syndrome. Eur. J. Hum. Genet. 13(4), 414–421 (2005). doi:10.1038/sj.ejhg.5201361
Kornak U., Reynders E., Dimopoulou A., van Reeuwijk J., Fischer B., Rajab A., Budde B., Nurnberg P., Foulquier F.: Group, a.D.-t.S., lefeber, D., urban, Z., gruenewald, S., annaert, W., brunner, H.G., van bokhoven, H., wevers, R., morava, E., matthijs, G., van maldergem, L., mundlos, S.: impaired glycosylation and cutis laxa caused by mutations in the vesicular H + −ATPase subunit ATP6V0A2. Nat. Genet. 40(1), 32–34 (2008). doi:10.1038/ng.2007.45
Wada Y., Dell A., Haslam S.M., Tissot B., Canis K., Azadi P., Backstrom M., Costello C.E., Hansson G.C., Hiki Y., Ishihara M., Ito H., Kakehi K., Karlsson N., Hayes C.E., Kato K., Kawasaki N., Khoo K.H., Kobayashi K., Kolarich D., Kondo A., Lebrilla C., Nakano M., Narimatsu H., Novak J., Novotny M.V., Ohno E., Packer N.H., Palaima E., Renfrow M.B., Tajiri M., Thomsson K.A., Yagi H., Yu S.Y., Taniguchi N.: Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol. Cell. Proteomics. 9(4), 719–727 (2010). doi:10.1074/mcp.M900450-MCP200
Acknowledgments
The author thanks Prof Marquardt (University of Münster), Dr. Yuasa (Tottori University) and Dr. Okamoto (Osaka Medical Center and Research Institute for Maternal and Child Health) for providing serum samples from CDG patients.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wada, Y. Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation. Glycoconj J 33, 297–307 (2016). https://doi.org/10.1007/s10719-015-9636-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-015-9636-0